OTC Markets OTCPK - Delayed Quote USD
Recce Pharmaceuticals Ltd (RECEF)
At close: October 7 at 4:00 PM EDT
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Cash Flows from Used in Operating Activities Direct
-13,008.6580
-13,008.6580
-12,687.3680
-9,010.2620
-7,855.8490
--
Investing Cash Flow
-141.8950
-141.8950
-38.6330
-40.3450
-76.0070
--
Financing Cash Flow
16,004.1610
16,004.1610
2,705.6460
-240.4990
26,122.7040
--
End Cash Position
4,415.1850
4,415.1850
1,561.5790
11,581.9340
20,873.0400
--
Interest Paid Supplemental Data
56.4430
--
--
--
--
56.4430
Capital Expenditure
-141.8950
-141.8950
-38.6330
-40.3450
-76.0070
--
Issuance of Capital Stock
11,146.1750
11,146.1750
102.0430
287.4080
28,056.2760
--
Issuance of Debt
10,089.3580
10,089.3580
2,878.1070
--
--
612.4630
Repayment of Debt
-4,203.7620
-4,203.7620
--
--
--
-1,349.8700
Repurchase of Capital Stock
--
--
--
--
-1,718.6750
--
Free Cash Flow
-13,150.5530
-13,150.5530
-12,726.0010
-9,050.6070
-7,931.8560
--
6/30/2020 - 8/12/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade